https://orcid.org/0000-0002-0369-5341
Citations (20)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (3)
Juan Eduardo Megías-Vericat, David Martínez-Cuadrón, Antonio Solana-Altabella & Pau Montesinos. (2020) Precision medicine in acute myeloid leukemia: where are we now and what does the future hold?. Expert Review of Hematology 13:10, pages 1057-1065.
Read now
Read now
David B. Altshuler, Padma Kadiyala, Felipe J. Nuñez, Fernando M. Nuñez, Stephen Carney, Mahmoud S. Alghamri, Maria B. Garcia-Fabiani, Antonela S. Asad, Alejandro J. Nicola Candia, Marianela Candolfi, Joerg Lahann, James J. Moon, Anna Schwendeman, Pedro R. Lowenstein & Maria G. Castro. (2020) Prospects of biological and synthetic pharmacotherapies for glioblastoma. Expert Opinion on Biological Therapy 20:3, pages 305-317.
Read now
Read now
Anneke D. van Dijk, Eveline S. J. M. de Bont & Steven M. Kornblau. (2020) Targeted therapy in acute myeloid leukemia: current status and new insights from a proteomic perspective. Expert Review of Proteomics 17:1, pages 1-10.
Read now
Read now
Articles from other publishers (17)
Shiqi Nong, Xiaoyue Han, Yu Xiang, Yuran Qian, Yuhao Wei, Tingyue Zhang, Keyue Tian, Kai Shen, Jing Yang & Xuelei Ma. (2023) Metabolic reprogramming in cancer: Mechanisms and therapeutics. MedComm 4:2.
Crossref
Crossref
Stephen B. Baylin. 2017. Holland‐Frei Cancer Medicine. Holland‐Frei Cancer Medicine
1
13
.
Mohsen Karami Fath, Kimiya Babakhaniyan, Mehran Anjomrooz, Mohammadrasoul Jalalifar, Seyed Danial Alizadeh, Zeinab Pourghasem, Parisa Abbasi Oshagh, Ali Azargoonjahromi, Faezeh Almasi, Hafza Zahira Manzoor, Bahman Khalesi, Navid Pourzardosht, Saeed Khalili & Zahra Payandeh. (2022) Recent Advances in Glioma Cancer Treatment: Conventional and Epigenetic Realms. Vaccines 10:9, pages 1448.
Crossref
Crossref
Wangqi Tian, Weitong Zhang, Yifan Wang, Ruyi Jin, Yuwei Wang, Hui Guo, Yuping Tang & Xiaojun Yao. (2022) Recent advances of IDH1 mutant inhibitor in cancer therapy. Frontiers in Pharmacology 13.
Crossref
Crossref
Aida Vitkevičienė, Giedrė Skliutė, Andrius Žučenka, Veronika Borutinskaitė & Rūta Navakauskienė. (2022) Potential Prognostic Markers for Relapsed/Refractory vs. Responsive Acute Myeloid Leukemia. Cancers 14:11, pages 2752.
Crossref
Crossref
Quanjun Yang, Juan Hao, Mengyi Chi, Yaxian Wang, Jie Li, Jinlu Huang, Jianping Zhang, Mengqi Zhang, Jin Lu, Shumin Zhou, Ting Yuan, Zan Shen, Shuier Zheng & Cheng Guo. (2022) D2HGDH-mediated D2HG catabolism enhances the anti-tumor activities of CAR-T cells in an immunosuppressive microenvironment. Molecular Therapy 30:3, pages 1188-1200.
Crossref
Crossref
Svetlana B. Panina, Jingqi Pei & Natalia V. Kirienko. (2021) Mitochondrial metabolism as a target for acute myeloid leukemia treatment. Cancer & Metabolism 9:1.
Crossref
Crossref
Fu-Ju Chou, Yang Liu, Fengchao Lang & Chunzhang Yang. (2021) D-2-Hydroxyglutarate in Glioma Biology. Cells 10:9, pages 2345.
Crossref
Crossref
Chelsea Schiliro & Bonnie L. Firestein. (2021) Mechanisms of Metabolic Reprogramming in Cancer Cells Supporting Enhanced Growth and Proliferation. Cells 10:5, pages 1056.
Crossref
Crossref
Zoltán N. Oltvai, Susan E. Harley, David Koes, Stephen Michel, Erica D. Warlick, Andrew C. Nelson, Sophia Yohe & Pawel Mroz. (2021)
Assessing acquired resistance to IDH1 inhibitor therapy by full-exon
IDH1
sequencing and structural modeling
. Molecular Case Studies 7:2, pages a006007.
Crossref
Crossref
Claudia Sargas, Rosa Ayala, María Carmen Chillón, María J. Larráyoz, Estrella Carrillo-Cruz, Cristina Bilbao, Manuel Yébenes-Ramírez, Marta Llop, Inmaculada Rapado, Ramón García-Sanz, Iria Vázquez, Elena Soria, Yanira Florido-Ortega, Kamila Janusz, Carmen Botella, Josefina Serrano, David Martínez-Cuadrón, Juan Bergua, Mari Luz Amigo, Pilar Martínez-Sánchez, Mar Tormo, Teresa Bernal, Pilar Herrera-Puente, Raimundo García, Lorenzo Algarra, María J. Sayas, Lisette Costilla-Barriga, Esther Pérez-Santolalla, Inmaculada Marchante, Esperanza Lavilla-Rubira, Víctor Noriega, Juan M. Alonso-Domínguez, Miguel Á. Sanz, Joaquín Sánchez-Garcia, María T. Gómez-Casares, José A. Pérez-Simón, María J. Calasanz, Marcos González-Díaz, Joaquín Martínez-López, Eva Barragán & Pau Montesinos. (2020) Networking for advanced molecular diagnosis in acute myeloid leukemia patients is possible: the PETHEMA NGS-AML project. Haematologica 106:12, pages 3079-3089.
Crossref
Crossref
Michael Heuser, Neil Palmisiano, Ioannis Mantzaris, Alice Mims, Courtney DiNardo, Lewis R. Silverman, Eunice S. Wang, Walter Fiedler, Claudia Baldus, Sebastian Schwind, Timothy Pardee, Alexander E. Perl, Charles Cai, Stefan Kaulfuss, Eleni Lagkadinou, Christine Rentzsch, Markus Wagner, Gary Wilkinson, Bingyan Wu, Michael Jeffers, Isabelle Genvresse & Alwin Krämer. (2020) Safety and efficacy of BAY1436032 in IDH1-mutant AML: phase I study results. Leukemia 34:11, pages 2903-2913.
Crossref
Crossref
Maria Hernandez-Valladares, Øystein Bruserud & Frode Selheim. (2020) The Implementation of Mass Spectrometry-Based Proteomics Workflows in Clinical Routines of Acute Myeloid Leukemia: Applicability and Perspectives. International Journal of Molecular Sciences 21:18, pages 6830.
Crossref
Crossref
Robert D. Leone & Jonathan D. Powell. (2020) Metabolism of immune cells in cancer. Nature Reviews Cancer 20:9, pages 516-531.
Crossref
Crossref
Juan Eduardo Megías-Vericat, Antonio Solana-Altabella, Octavio Ballesta-López, David Martínez-Cuadrón & Pau Montesinos. (2020) Drug-drug interactions of newly approved small molecule inhibitors for acute myeloid leukemia. Annals of Hematology 99:9, pages 1989-2007.
Crossref
Crossref
Silvia Park, Byung Sik Cho & Hee-Je Kim. (2020) New agents in acute myeloid leukemia (AML). BLOOD RESEARCH 55:S1, pages S14-S18.
Crossref
Crossref
. (2021) Ivosidenib – Another Feather in the Hat of Treatment for Acute Myeloid Leukemia. Indian Journal of Medical and Paediatric Oncology 41:04, pages 552-554.
Crossref
Crossref